Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

Lentigen Corporation

Address:
910 Clopper Road, Suite 200, South Building
--
Gaithersburg, MD 20878, USA
1-301-527-4200

Category: Drug Delivery

Used in the following map:

Maryland Biotech Industry Map

Lentigen Corporation is a biologics company focused on the development and commercialization of breakthrough treatments for human disease. It was founded by Boro Dropulic, with a mission to advance biomedicine and improve human health by the development of biotherapeutics, vaccines, protein therapeutics and tools for discovery research.

Lentigen's Lentiviral vectors (LV) technology platform is widely recognized as the most efficient method for delivery of genetic sequence information into cells to reprogram their function. The ability to efficiently and stably reprogram mammalian cells has numerous uses in biotechnology and biomedicine, including drug discovery, target validation, biologics manufacturing and cellular therapies.

Lentigen is focused on the development of novel biotherapeutics for the treatment of serious diseases with unmet need. Its therapeutic pipeline includes somatic cell therapies, stem cell therapies, vaccines, protein therapeutics. The company is engaged in the development of several vaccine candidates including VLP vaccines for pandemic influenza and Hepatitis C virus infection. Its vaccines are - LG611, a virus-like particle (VLP) vaccine for pandemic flu; LG811, a therapeutic vaccine for seasonal influenza; LG912, a vaccine for Hepatitis C virus infection; LG912, a vaccine for HIV/AIDS. The company's product pipeline includes: LG690, a T cell therapy indicated for the treatment of Graft versus Host Disease; LG631, a stem cell therapy indicated for the treatment of Glioblastoma Multiforme; LG889, a cell therapy consisting of CD34+ hematopoietic stem cells indicated for the treatment of Hemophilia A; etc.

Lentigen Corporation has partnerships with International AIDS Vaccine Initiative (IAVI), PATH (Program for Appropriate Technology in Health), University of Pennsylvania, Case Western Reserve University, University of Toronto, University of Wisconsin, Medical University of South Carolina, Invitrogen, etc.